Financials Enlivex Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart 15:56:00 2026-08-14 EDT			5-day change	1st Jan Change
1.370 ^EUR	-16.46%		-0.61%	-82.08%

07-28	Enlivex Ltd. announced that it expects to receive $400 million in funding	CI
07-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
EBIT ¹	-19.29	-25.8	-29.4	-15.89	-15.03	-20	-25
Change	-	-33.75%	-13.95%	45.95%	5.41%	-33.08%	-25%
Interest Paid	-0.89	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-14.47	-31.06	-29.07	-15.01	1,618	-20	-25
Change	-	-114.68%	6.41%	48.35%	10,877.77%	-101.24%	-25%
Net income ¹	-14.47	-31.06	-29.07	-15.01	1,236	-20	-25
Change	-	-114.68%	6.41%	48.35%	8,329.17%	-101.62%	-25%
Announcement Date	4/29/22	3/31/23	3/29/24	3/31/25	3/25/26	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-3.808	-3.864	-7.814	-6.404	-5.871	-5.677	-7.845	-6.783	-6.649	-5.628	-10.34	-4.151	-2.986	-3.119	-5.632	-	-	-2.557	-5.861	-4.7	-4.9	-5.1	-5.3	-	-	-	-
Change	-	-1.47%	-102.23%	18.04%	8.32%	3.3%	-38.19%	13.54%	1.98%	15.36%	-83.64%	59.84%	28.07%	-4.45%	-80.57%	-	-	-	-129.21%	19.81%	-4.26%	-4.08%	-3.92%	-	-	-	-
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-0.335	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	-4.736	-8.225	-9.913	-5.733	-7.189	-7.218	-6.792	-5.963	-9.095	-4.14	-3.096	-2.602	-5.176	-	-	-2.205	1,626	-4.7	-4.9	-5.1	-5.3	-	-	-	-
Change	-	-	-	-73.67%	-20.52%	42.17%	-25.4%	-0.4%	5.9%	12.21%	-52.52%	54.48%	25.22%	15.96%	-98.92%	-	-	-	73,827.85%	-100.29%	-4.26%	-4.08%	-3.92%	-	-	-	-
Net income ¹	-	-	-4.736	-8.225	-9.913	-5.733	-7.189	-7.218	-6.792	-5.963	-9.095	-4.14	-3.096	-2.602	-5.176	-	-	-2.205	1,243	-4.7	-4.9	-5.1	-5.3	-	-	-	-
Change	-	-	-	-73.67%	-20.52%	42.17%	-25.4%	-0.4%	5.9%	12.21%	-52.52%	54.48%	25.22%	15.96%	-98.92%	-	-	-	56,474.29%	-100.38%	-4.26%	-4.08%	-3.92%	-	-	-	-
Announcement Date	8/6/21	11/19/21	4/29/22	5/27/22	8/22/22	12/2/22	3/31/23	6/16/23	9/1/23	11/9/23	3/29/24	6/14/24	8/30/24	11/29/24	3/31/25	5/30/25	8/29/25	11/14/25	3/25/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	4/29/22	3/31/23	3/29/24	3/31/25	3/25/26	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025
CAPEX ¹	1.019	1.625	8.122	0.236	0.103	0.068
Change	-	59.47%	399.82%	-97.09%	-56.36%	-33.98%
Free Cash Flow (FCF) ¹	-5.607	-10.19	-18.68	-17.77	-5.407	-1,737
Change	-	-81.68%	-83.36%	4.88%	69.57%	-32,026.04%
Announcement Date	4/30/21	4/29/22	3/31/23	3/29/24	3/31/25	3/25/26

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-	-	-
EBT Margin (%)	-	-	-	-	-	-	-	-
Net margin (%)	-	-	-	-	-	-	-	-
FCF margin (%)	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	87.33%	-0.85%	-	-
Profitability
ROA	-21.12%	-17.79%	-19.81%	-30.09%	-30.1%	-0.8%	-	-
ROE	-50.56%	-24.01%	-43.78%	-66.88%	-55.95%	126.17%	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-0.79%	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EPS ¹	-	-12.15	-25.35	-23.4	-10.95	382.2	-1.15	-0.21
Change	-	-	-108.64%	7.69%	53.21%	3,590.41%	-100.3%	81.74%
Nbr of stocks (in thousands)	-	1,222	1,227	1,240	1,466	15,825	17,485	17,485
Announcement Date	-	4/29/22	3/31/23	3/29/24	3/31/25	3/25/26	-	-